These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 3621175)

  • 1. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
    Conway JG; Neptun DA; Garvey LK; Popp JA
    Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical increase in peroxisomal cyanide-insensitive respiration following dietary exposure to WY-14,643 in the perfused liver.
    Bojes HK; Sausen PJ; Cattley RC; Keller BJ; Thurman RG
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):202-9. PubMed ID: 8661345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
    Danis M; Kauffman FC; Evans RK; Thurman RG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):383-8. PubMed ID: 7288627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and biliary glutathione disulfide in the perfused vitamin E-deficient rat liver.
    Hill KE; Taylor MA; Ziegler DM; Burk RF
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):373-83. PubMed ID: 2727389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
    Zhong Z; Kauffman FC; Thurman RG
    Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
    Belinsky SA; Kauffman FC; Thurman RG
    Mol Pharmacol; 1989 Apr; 35(4):512-8. PubMed ID: 2704372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferators activate Kupffer cells in vivo.
    Bojes HK; Thurman RG
    Cancer Res; 1996 Jan; 56(1):1-4. PubMed ID: 8548746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine.
    Ballatori N; Truong AT
    Mol Pharmacol; 1990 Jul; 38(1):64-71. PubMed ID: 2115113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fatty acids on formation, distribution, storage, and release of benzo(a)pyrene phenols and glucuronides in the isolated perfused rat liver.
    Zhong Z; Gao W; Kauffman FC; Thurman RG
    Cancer Res; 1989 Apr; 49(8):2012-6. PubMed ID: 2702643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of zone-specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule.
    Olson MJ; Handler JA; Thurman RG
    Mol Pharmacol; 1986 Dec; 30(6):520-5. PubMed ID: 3097499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat.
    Huber W; Kraupp-Grasl B; Esterbauer H; Schulte-Hermann R
    Cancer Res; 1991 Apr; 51(7):1789-92. PubMed ID: 2004363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalase-dependent ethanol oxidation in perfused rat liver. Requirement for fatty-acid-stimulated H2O2 production by peroxisomes.
    Handler JA; Thurman RG
    Eur J Biochem; 1988 Sep; 176(2):477-84. PubMed ID: 3416882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased biliary GSSG efflux from rat livers perfused with thiocarbamide substrates for the flavin-containing monooxygenase.
    Krieter PA; Ziegler DM; Hill KE; Burk RF
    Mol Pharmacol; 1984 Jul; 26(1):122-7. PubMed ID: 6431260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
    Lake BG; Gray TJ; Körösi SA; Walters DG
    Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic differences in enzymes associated with peroxisome proliferation and hydrogen peroxide metabolism in inbred mouse strains.
    Butler EG; England PJ; Williams GM
    Carcinogenesis; 1988 Aug; 9(8):1459-63. PubMed ID: 3402042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
    Belinsky SA; Kauffman FC; Thurman RG
    Mol Pharmacol; 1984 Nov; 26(3):574-81. PubMed ID: 6333582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.